Crenezumab (Anti-Amyloid Beta)
Product Specifications
CAS Number
1095207-05-8
Synonyms
MABT 5102A; RG 7412
Target
Beta Amyloid
Applications
Neuronal Signaling
Additionnal Information
Crenezumab (Anti-Amyloid Beta) is a fully humanized immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimer's disease research. MW: 143.58 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040304-100 1x 100 µL
CD106 / VCAM1 (B-K9), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470043-100 1x 100 µL
P21 / WAF1 (WA-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680461-500 1x 500 µL
Chromogranin A (PHE5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041170-100 1x 100 µL
Vimentin (VM1170), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402122-500 1x 500 µL
Ubiquitin (Autophagy Marker) (UBB/2122), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details